Acta Scientific Neurology (ASNE) (ISSN: 2582-1121)

Case Report Volume 4 Issue 6

Intramedullary Spinal Cord Metastasis from Urothelial Carcinoma

Michael Spinrad1, Pouya Entezami1*, David Jones2 and John Dalfino1

1Department of Neurosurgery, Albany Medical College, Albany, NY, USA
2Department of Pathology, Albany Medical College, Albany, NY, USA

*Corresponding Author: Pouya Entezami, Department of Neurosurgery, Albany Medical College, Albany, NY, USA.

Received: May 01, 2021; Published: May 25, 2021


&nbs; Intramedullary spinal cord metastases (ISCM) are rare neoplasms often associated with significant neurological deterioration. Spinal cord metastases secondary to bladder carcinoma are particularly rare. We report a 56-year-old male found to have an intradural intramedullary lesion at T12. A bladder mass was also discovered on ultrasound, as well as additional systemic metastases. A dorsal approach was undertaken for the spinal cord lesion. Bladder carcinoma and ISCM were confirmed histopathologically. ISCM carries a poor prognosis and information is limited to case reports and series. Early recognition could improve patient therapy and quality of life.

Keywords: Bladder Carcinoma; Intramedullary Spinal Cord Metastasis; Neurooncology; Spinal Cord Surgery


  1. Crowley RW., et al. “Intramedullary spinal cord metastasis from bladder carcinoma: case report”. Neurosurgery3 (2008): E611-612 discussion E12.
  2. Abdulazim A., et al. “Intramedullary spinal cord metastasis and multiple brain metastases from urothelial carcinoma”. Journal of Clinical Neuroscience 10 (2011): 1405-1407.
  3. Dam-Hieu P., et al. “Retrospective study of 19 patients with intramedullary spinal cord metastasis”. Clinical Neurology and Neurosurgery 1 (2009): 10-17.
  4. Anderson TS., et al. “Neurologic complications of bladder carcinoma: a review of 359 cases”. Cancer9 (2003): 2267-2272.
  5. Sung WS., et al. “Intramedullary spinal cord metastases: a 20-year institutional experience with a comprehensive literature review”. World Neurosurgery 79 (2013): 576-584.
  6. Costigan DA and Winkelman MD. “Intramedullary spinal cord metastasis. A clinicopathological study of 13 cases”. Journal of Neurosurgery2 (1985): 227-233.
  7. Goyal A., et al. “Intramedullary spinal cord metastases: an institutional review of survival and outcomes”. Journal of Neurooncology2 (2019): 347-354.
  8. Diamantopoulos LN., et al. “Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature”. Clinical Genitourinary Cancer 3 (2020): e266-e276.
  9. Schiff D and O'Neill BP. “Intramedullary spinal cord metastases: clinical features and treatment outcome”. Neurology4 (1996): 906-912.
  10. Hrabalek L. “Intramedullary spinal cord metastases: review of the literature”. Biomedical Papers is a Journal of Palacký University Olomouc, Faculty of Medicine and Dentistry, Olomouc, Czech Republic 2 (2010): 117-122.
  11. Lv J., et al. “Intramedullary spinal cord metastasis in malignancies: an institutional analysis and review”. OncoTargets and Therapy 12 (2019): 4741-4753.
  12. Kalayci M., et al. “Intramedullary spinal cord metastases: diagnosis and treatment - an illustrated review”. Acta Neurochirurgica (Wien) 2004 146.12 (2004): 1347-1354 discussion 54.
  13. Rykken JB., et al. “Intramedullary spinal cord metastases: MRI and relevant clinical features from a 13-year institutional case series”. AJNR American Journal of Neuroradiology10 (2013): 2043-2049.
  14. Strickland BA., et al. “The surgical treatment of metastatic spine tumors within the intramedullary compartment”. Journal of Neurosurgey Spine1 (2018): 79-87.
  15. Gasser T., et al. “Surgical treatment of intramedullary spinal cord metastases of systemic cancer: functional outcome and prognosis”. Journal of Neurooncology2 (2005): 163-168.


Citation: Pouya Entezami., et al. “Intramedullary Spinal Cord Metastasis from Urothelial Carcinoma”. Acta Scientific Neurology 4.6 (2021): 121-124.


Copyright: © 2021 Pouya Entezami., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate32%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US